Delivery Order SPE2DB22D3016-SPE2DB24FBES0

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,944.30, is for the delivery of Lamotrigine ODT 100 mg tablets. This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,156.56 firm fixed-price contract is for the supply of Lamotrigine ODT 200 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 100 mg tablets. The contract has a ceiling value of $1,464.53 and a period of performance ending on September 24, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of Lamotrigine ODT 200 mg tablets. The contract has a total ceiling value of $1,308.50 and is a firm fixed-price delivery order with a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of lamotrigine orally disintegrating tablets (50 mg, 30-count). The contract has a ceiling value of $2,561.59 and a period of performance ending on June 25, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,258,825 units of the pharmaceutical product LAMOTRIGINE ODT 50 MG TABLET 30S. The contract has a ceiling value of $2,579.51 and a period of performance through April 15, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,314.17 contract is for the supply of 30-count tablets of the generic medication lamotrigine orally disintegrating tablets (ODT) in 25 milligram strength. The delivery order has a performance period through March 27, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug...
This is a $1,059.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 200 mg tablets, a neurological medication, with a performance period through June 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is a critical supplier of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LAMOTRIGINE ODT 100 MG TABLET 30S medication, with a ceiling value of $2,945.58 and an ultimate completion date of June 18, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBES0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ODT 200 mg tablets. The contract has a ceiling value of $3,928.79 and an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/19/24, 9:12 AM